Results 11 to 20 of about 556,908 (299)

Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder [PDF]

open access: bronzeThe Journal of Clinical Endocrinology & Metabolism, 2005
AbstractContext: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition.Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD.Design: The ...
James A. Simon   +12 more
semanticscholar   +4 more sources

Contact allergy to a testosterone patch [PDF]

open access: bronzeContact Dermatitis, 1998
D.A. Buckley   +2 more
semanticscholar   +5 more sources

Open-Label Pilot Study of Testosterone Patch Therapy in Men With Opioid-Induced Androgen Deficiency

open access: bronzeThe Journal of Pain, 2006
We conducted a 24-week open-label pilot study of testosterone (T) patch therapy in 23 men with opioid-induced androgen deficiency (OPIAD). The T dosage was 5 mg/day for the first 12 weeks and 7.5 mg/day for the second 12 weeks. Seven subjects discontinued prematurely: 4 for noncompliance, 2 for skin irritation and 1 for hepatitis C treatment.
Henry Daniell   +2 more
semanticscholar   +5 more sources

Transfer of Transdermally Applied Testosterone to Clothing: A Comparison of a Testosterone Patch Versus a Testosterone Gel

open access: closedThe Journal of Sexual Medicine, 2005
ABSTRACT Aim To  assess  the  amount  of  testosterone  transferred  from  the  abdominal  application  sites  of a transdermal testosterone patch and a transdermal testosterone gel to cotton T-shirts worn for 24 hours during each treatment. Methods
Norman A. Mazer   +5 more
semanticscholar   +5 more sources

The testosterone patch for women [PDF]

open access: yesInternational Journal of Impotence Research, 2005
Has the FDA discriminated against female sexual dysfunction by not endorsing Procter & Gamble's (P&G) Intrinsa? Has the pendulum swung so far to the right that drugs for sexual medicine receive undue scrutiny? Why is testosterone replacement therapy available for men, but not for women? How should the pharmaceutical industry proceed with future studies?
S A Kingsberg
openaire   +4 more sources

Intrinsa: testosterone patch for low sexual desire in women [PDF]

open access: yesPrescriber, 2008
AbstractIntrinsa, a transdermal testosterone patch, is licensed for women with hypoactive sexual desire disorder following bilateral oophorectomy or hysterectomy. Here, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Panay comments on its role in therapy.
Nick Panay, Steve Chaplin
openaire   +3 more sources

Local and Systemic Complications of Local Testosterone Patches and Gels

open access: goldJournal of Pharmaceutical Research International, 2021
In recent decades, testosterone therapy has gained the attention of many researchers due to the increased demand for this modality worldwide, the increased average age of the different populations, and increased awareness of the potential uses of the modality in clinical settings.
Fahad Ahmed Al-Zahrani   +10 more
openalex   +4 more sources

Comparison of the Steady-State Pharmacokinetics, Metabolism, and Variability of a Transdermal Testosterone Patch Versus a Transdermal Testosterone Gel in Hypogonadal Men

open access: yesThe Journal of Sexual Medicine, 2005
ABSTRACT Aim To compare the pharmacokinetics (PK), metabolism, intra- and inter-subject variability of a permeation-enhanced testosterone patch versus a topical testosterone gel. Methods 28 hypogonadal men were treated with a ...
Jerome Fischer   +5 more
openaire   +4 more sources

Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: A Case Report [PDF]

open access: yesHuman Reproduction, 2007
Achieving ovulation in women with Kallmann's syndrome requires both exogenous FSH and LH to successfully stimulate follicular maturation and ovarian steroidogenesis. We present a case of a woman with Kallmann's syndrome, who had poor ovarian response to stimulation by exogenous gonadotrophins.
C. S. Sipe, Bradley J. Van Voorhis
openaire   +4 more sources

Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism [PDF]

open access: yesInternational Journal of Andrology, 2005
SummaryClinical studies suggest there may be a threshold concentration of serum testosterone below which replacement will result in skeletal and psychological benefit. We evaluated the response to testosterone in men with borderline hypogonadism. A randomized double‐blind placebo‐controlled trial in 39 men over age 40 years presenting with sexual ...
Merza, Z.   +8 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy